CN113136363B - 一种脂肪源干细胞的分离制备方法及脂肪源干细胞 - Google Patents
一种脂肪源干细胞的分离制备方法及脂肪源干细胞 Download PDFInfo
- Publication number
- CN113136363B CN113136363B CN202010058329.9A CN202010058329A CN113136363B CN 113136363 B CN113136363 B CN 113136363B CN 202010058329 A CN202010058329 A CN 202010058329A CN 113136363 B CN113136363 B CN 113136363B
- Authority
- CN
- China
- Prior art keywords
- adipose
- adipose tissue
- stem cells
- derived stem
- centrifuging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 238000000926 separation method Methods 0.000 title abstract description 9
- 210000000577 adipose tissue Anatomy 0.000 claims abstract description 119
- 210000004027 cell Anatomy 0.000 claims abstract description 85
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 59
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 59
- 239000000243 solution Substances 0.000 claims abstract description 53
- 239000013049 sediment Substances 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 49
- 102000029816 Collagenase Human genes 0.000 claims abstract description 46
- 108060005980 Collagenase Proteins 0.000 claims abstract description 46
- 229960002424 collagenase Drugs 0.000 claims abstract description 46
- 239000002504 physiological saline solution Substances 0.000 claims abstract description 42
- 230000000694 effects Effects 0.000 claims abstract description 29
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- 238000005406 washing Methods 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims description 40
- 239000007924 injection Substances 0.000 claims description 39
- 238000002347 injection Methods 0.000 claims description 39
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 28
- 210000001519 tissue Anatomy 0.000 claims description 26
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 24
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 24
- 229930182555 Penicillin Natural products 0.000 claims description 12
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 12
- 229940049954 penicillin Drugs 0.000 claims description 12
- 229940054269 sodium pyruvate Drugs 0.000 claims description 12
- 229960005322 streptomycin Drugs 0.000 claims description 12
- 239000006285 cell suspension Substances 0.000 claims description 11
- 230000029087 digestion Effects 0.000 abstract description 15
- 239000000725 suspension Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 239000007789 gas Substances 0.000 description 13
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 11
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 11
- 238000007443 liposuction Methods 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 7
- 239000004519 grease Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 208000023275 Autoimmune disease Diseases 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 5
- 208000027205 Congenital disease Diseases 0.000 description 5
- 208000028782 Hereditary disease Diseases 0.000 description 5
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 5
- 208000026350 Inborn Genetic disease Diseases 0.000 description 5
- 208000024556 Mendelian disease Diseases 0.000 description 5
- 241000589884 Treponema pallidum Species 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000036449 good health Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 210000001616 monocyte Anatomy 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- 238000004378 air conditioning Methods 0.000 description 4
- 238000012864 cross contamination Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 238000003570 cell viability assay Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000010297 mechanical methods and process Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000003320 cell separation method Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002676 facial rejuvenation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 230000002669 organ and tissue protective effect Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000000229 preadipocyte Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010058329.9A CN113136363B (zh) | 2020-01-19 | 2020-01-19 | 一种脂肪源干细胞的分离制备方法及脂肪源干细胞 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010058329.9A CN113136363B (zh) | 2020-01-19 | 2020-01-19 | 一种脂肪源干细胞的分离制备方法及脂肪源干细胞 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113136363A CN113136363A (zh) | 2021-07-20 |
CN113136363B true CN113136363B (zh) | 2023-10-20 |
Family
ID=76808735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010058329.9A Active CN113136363B (zh) | 2020-01-19 | 2020-01-19 | 一种脂肪源干细胞的分离制备方法及脂肪源干细胞 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113136363B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673745A (zh) * | 2015-02-05 | 2015-06-03 | 广州赛莱拉干细胞科技股份有限公司 | 一种猪脂肪干细胞的分离培养方法 |
CN107475190A (zh) * | 2017-10-13 | 2017-12-15 | 上海莱馥医疗科技有限公司 | 一种脂肪svf细胞临床级高效制备和冻存的方法及其用途 |
CN110577930A (zh) * | 2019-09-30 | 2019-12-17 | 重庆赛托斯创生物科技发展有限公司 | 一种多联管式脂肪干细胞提取方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110008301A1 (en) * | 2008-03-15 | 2011-01-13 | Trivedi H L | Human adipose derived insulin making mesenchymal stem cells for treating diabetes mellitus |
-
2020
- 2020-01-19 CN CN202010058329.9A patent/CN113136363B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673745A (zh) * | 2015-02-05 | 2015-06-03 | 广州赛莱拉干细胞科技股份有限公司 | 一种猪脂肪干细胞的分离培养方法 |
CN107475190A (zh) * | 2017-10-13 | 2017-12-15 | 上海莱馥医疗科技有限公司 | 一种脂肪svf细胞临床级高效制备和冻存的方法及其用途 |
CN110577930A (zh) * | 2019-09-30 | 2019-12-17 | 重庆赛托斯创生物科技发展有限公司 | 一种多联管式脂肪干细胞提取方法 |
Non-Patent Citations (1)
Title |
---|
丙酮酸盐对组织细胞的保护作用;左珊珊等;全国第四次麻醉药理学学术会议暨2013年贵州省麻醉学术年会;188-193 * |
Also Published As
Publication number | Publication date |
---|---|
CN113136363A (zh) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107475190B (zh) | 一种脂肪svf细胞临床级高效制备和冻存的方法及其用途 | |
CN104450611B (zh) | 一种人羊膜间充质干细胞原代分离及培养方法 | |
US20130183273A1 (en) | Native wharton's jelly stem cells and their purification | |
CN112760288B (zh) | 一种肺癌类器官专用培养基及培养方法 | |
CN115322964B (zh) | 一种3d培养羊膜间充质干细胞种子库构建方法 | |
TW201510223A (zh) | 一種組織勻漿法分離活細胞構建細胞庫的方法 | |
CN111088226A (zh) | 一种胎盘间充质干细胞外泌体的制备和储存方法 | |
CN112063583A (zh) | 一种从脂肪组织中高效分离提取脂肪间充质干细胞的方法 | |
CN114177203B (zh) | 脐带血浓缩细胞治疗卵巢早衰的细胞治疗剂 | |
CN111467374A (zh) | 一种新型白细胞提取物混合因子及其制备方法 | |
CN113136363B (zh) | 一种脂肪源干细胞的分离制备方法及脂肪源干细胞 | |
CN106399236A (zh) | 一种促进脂肪干细胞生长的培养方法 | |
CN110885784B (zh) | 一种临床应用级脂肪干细胞及其制备方法 | |
TWI640625B (zh) | 體外快速切碎脂肪組織以分離活細胞之方法 | |
CN113133443A (zh) | 一种脂肪组织保护液及其应用 | |
CN116515745A (zh) | 一种用于女性卵巢早衰生殖修复的干细胞制备方法 | |
CN114276980B (zh) | 一种培养适合临床应用的胰岛细胞的方法 | |
CN110643572A (zh) | 脐带间充质干细胞的分离纯化方法 | |
CN111621473A (zh) | 一种新型人源脂肪干细胞制剂的制备方法 | |
WO2022056991A1 (zh) | 脐带来源的间充质干细胞及其制备方法和应用 | |
CN109536449B (zh) | 从异常组织中分离单细胞的方法 | |
CN112626019A (zh) | 一种眼角膜及角膜缘单细胞悬液的制备方法 | |
CN114540296B (zh) | 一种复合外泌体的制备方法及其在定向增强血管生成能力方面的应用 | |
CN111040994A (zh) | 一种高效分离脂肪来源脂肪间充质干细胞的方法 | |
CN111979188A (zh) | 一种胎盘间充质干细胞分离培养扩增方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 200333 4th floor, building 15, Lane 879, Zhongjiang Road, Putuo District, Shanghai Applicant after: SHANGHAI ICELL BIOTECHNOLOGY Co.,Ltd. Applicant after: Beijing victory Biotechnology Co.,Ltd. Applicant after: Chongqing Saiao Biotechnology Co.,Ltd. Address before: 200333 4th floor, building 15, Lane 879, Zhongjiang Road, Putuo District, Shanghai Applicant before: SHANGHAI ICELL BIOTECHNOLOGY Co.,Ltd. Applicant before: Beijing victory Biotechnology Co.,Ltd. Applicant before: Chongqing United Stem Cell Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for isolating and preparing adipose derived stem cells and adipose derived stem cells Granted publication date: 20231020 Pledgee: Bank of Communications Co.,Ltd. Shanghai Changning Branch Pledgor: SHANGHAI ICELL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2024980017047 |